Prestige Wealth Management Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1K Hold
14
﹤0.01% 886
2026
Q1
$905 Hold
14
﹤0.01% 875
2025
Q4
$943 Hold
14
﹤0.01% 878
2025
Q3
$1.03K Hold
14
﹤0.01% 847
2025
Q2
$729 Hold
14
﹤0.01% 892
2025
Q1
$894 Hold
14
﹤0.01% 863
2024
Q4
$670 Hold
14
﹤0.01% 935
2024
Q3
$802 Hold
14
﹤0.01% 910
2024
Q2
$734 Hold
14
﹤0.01% 874
2024
Q1
$570 Buy
+14
New +$525 ﹤0.01% 935
2023
Q4
Sell
-8
Closed -$306 1047
2023
Q3
$306 Buy
+8
New +$328 ﹤0.01% 1006
2023
Q1
Sell
-50
Closed -$2.85K 1107
2022
Q4
$2.85K Buy
+50
New +$2.56K ﹤0.01% 753
2021
Q4
Sell
-12
Closed 1016
2021
Q3
$0 Buy
+12
New +$502 ﹤0.01% 1005

Other funds holding HALO

Prestige Wealth Management Group's HALO Position: Q2 2026 in Review

Prestige Wealth Management Group held its Halozyme (HALO) position steady in Q2 2026 at 14 shares worth $1.1K. The position accounts for ﹤0.01% of the portfolio, ranked #886.

Prestige Wealth Management Group first reported a position in HALO in Q3 2021 and has held it in 13 quarters since. The position peaked at $2.85K in Q4 2022. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Prestige Wealth Management Group held 14 shares of Halozyme worth $1.1K as of Q2 2026.
  • Prestige Wealth Management Group left its Halozyme share count unchanged in Q2 2026.
  • Halozyme made up ﹤0.01% of Prestige Wealth Management Group's portfolio in Q2 2026, its #886 holding.
  • Prestige Wealth Management Group first reported a position in Halozyme in Q3 2021 and has held it in 13 quarters since.
  • Prestige Wealth Management Group's Halozyme position peaked at $2.85K in Q4 2022.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.